Abstract: Process for producing a hydrogen-containing product and one or more liquid water products using catalytic steam-hydrocarbon reforming. In the process, a portion of the make-up water is heated by the reformate and another portion of the make-up water is heated by the combustion product gas prior to introducing the make-up water to a deaerator. Water in the combustion product gas is condensed to form a liquid water product. The process may be integrated with a thermal water desalination process.

Abstract: A process for producing a H2-containing product gas and purified water from an integrated catalytic steam-hydrocarbon reforming and thermal water purification process. Raw water, such as salt water, is heated by indirect heat transfer with reformate from the catalytic steam reforming process for purifying raw water in one of a multiple effect distillation process and a multi-stage flash process.

Abstract: A process for producing a H2-containing product gas and purified water from an integrated catalytic steam-hydrocarbon reforming and thermal water purification process. Raw water, such as salt water, is heated by indirect heat transfer with reformate from the catalytic steam reforming process for purifying raw water in one of a multiple effect distillation process and a multi-stage flash process.

Abstract: A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a human in need thereof of an effective amount of a compound of the formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a human in need thereof of an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: Systems and methods for supply and delivery of a product incorporated into a carrier are provided. In one embodiment, the invention comprises a system that comprises a fresh storage vessel for receiving and storing fresh. The system further includes a fresh transferring apparatus communicably linked to the fresh storage vessel for transferring of fresh to a user when the user is connected to the transferring apparatus. The system further includes a spent storage vessel for receiving and storing spent (spent being defined as fresh with at least some product and/or product element removed therefrom), and a spent transferring apparatus communicably linked to the spent storage vessel for transferring spent from a user when the user is connected to the transferring apparatus. Optionally, the system further includes of an intermediate spent storage vessel disposed in the communicable connection between the spent transferring apparatus and the spent storage vessel.

Abstract: Systems and methods are provided for distributing a product, like hydrogen, contained in a carrier to a user, and for recovering the spent from the user. In one embodiment, the invention is a system for distributing a product releasably incorporated within a carrier, recovering spent, and conveying spent to a rehabilitation facility. In this embodiment, the system comprises a mobile delivery vehicle, the vehicle comprising a first storage vessel for storing fresh and for dispensing fresh using a connected fresh dispensing apparatus and for receiving and storing spent from a spent dispensing apparatus, the storage vessel further including means for separating fresh from spent. The system further includes fresh, spent, and a first user. The first user comprises a fresh storage vessel for receiving, storing, and dispensing fresh, and further comprises a first spent storage vessel for receiving, storing, and dispensing spent.

Abstract: Systems and methods for distributing a product releasably incorporated within a carrier, and for removing the product and returning the carrier for rehabilitation. In one embodiment, the system includes a first supply loop comprising a manufacturing facility for releasably incorporating a product into a first carrier to form fresh. The first loop further includes transportation means for conveying fresh to a first user, the first user including a fresh storage vessel for receiving and storage of fresh. The first user further comprises means for removing product from the carrier to form spent, and a spent storage vessel for receiving, storing, and dispensing of spent. The loop further includes means for returning the spent to a rehabilitation facility of the spent to form fresh wherein a product is contained in a carrier. The carrier may be in any physical state such as for example, solid, liquid, vapor, plasma, or any combination thereof.

Abstract: A compound of formula (I) wherein R1 and R3 are the same or different and represent ?O, hydrogen, C1-6alkyl, C1-6dialkyl, ?CHC1-C5alkyl, ?S, or a 5- or 6-membered aryl; R4 to R9 are the same or different and represent hydrogen, C1-6alkoxy, OCF3, OCH2CF3, O-cyclopropyl, OCH2-cyclopropyl, C1-C6alkyl, S-alkyl, NR210 where R10 is hydrogen or C1-6alkyl, halogen, NO2, OH, CH2OC1-C6alkyl, CH2OH, or CF3; Q1 is hydrogen, C1-6alkyl, C1-6dialkyl, C1-6alkoxy, NHAc, NR210 where R10 is hydrogen or C1-6alkyl, difluoro, fluoro, ?O, or OH; Q2, Q3, Q4 and Q5 are the same or different and represent hydrogen, C1-6alkoxy, OCF3, OCH2CF3, O-cyclopropyl, OCH2-cyclopropyl, C1-C6alkyl, S-alkyl, NR210 where R10 is hydrogen or C1-6alkyl, halogen, NO2, OH, CH2OC1-C6alkyl, CH2OH, or a 5- or 6-membered aryl; with the proviso that the compounds [4-(1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]-2-propionic acid, sodium salt and [4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetic acid are excluded; and pharmac

Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein R1 to R8, X, and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

Abstract: A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a human in need thereof of an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a mammal in need thereof of an effective amount of a compound of the formula (I) and/or a physiologically acceptable derivative thereof, wherein the substituents have the meaning given in the description. Disclosed are also novel compounds of formula (I) and processes for their preparation.

Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein R1 to R8, X, and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

Abstract: A process and apparatus for the on-site delivery of a gas having improved purity to from a container filled with liquid under pressure and integrated with a purifier. In the process a portion of the liquid is converted to vapor by reducing the pressure in the container and expanding the thus formed vapor through a pressure reducer generating refrigeration. The cooled vapor is warmed against incoming vapor prior to exit from the purifier.

Abstract: The present invention relates to novel quinoline derivatives such as compounds of the formula (I) which possess antagonist potency for the 5-HT6 receptor and/or are capable of selectively modulating the cannabinoid 2 receptor: and the use of such compounds or pharmaceutical compositions thereof in the treatment of CNS disorders.

Abstract: The present invention relates to novel indole derivatives such as compounds of the formula (I): which possess antagonist potency at the 5-HT6 receptor and the use of such compounds or pharmaceutically acceptable salts or solvates thereof in the treatment of Alzheimer's disease and other CNS disorders.

Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, B, D, Z, R1, R2a, R2b, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

Abstract: Compounds of formula (I) or derivatives thereof: wherein A, B, Z, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

Abstract: A compound of formula (I) wherein R1 and R3 are the same or different and represent ?O, hydrogen, C1-6alkyl, C1-6dialkyl, ?CHC1-C5alkyl, ?S, or a 5- or 6-membered aryl; R4 to R9 are the same or different and represent hydrogen, C1-6alkoxy, OCF3, OCH2CF3, O-cyclopropyl, OCH2-cyclopropyl, C1-C6alkyl, S-alkyl, NR210 where R10 is hydrogen or C1-6alkyl, halogen, NO2, OH, CH2OC1-C6alkyl, CH2OH, or CF3; Q1 is hydrogen, C1-6alkyl, C1-6dialkyl, C1-6alkoxy, NHAc, NR210 where R10 is hydrogen or C1-6alkyl, difluoro, fluoro, ?O, or OH; Q2, Q3, Q4 and Q5 are the same or different and represent hydrogen, C1-6alkoxy, OCF3, OCH2CF3, O-cyclopropyl, OCH2-cyclopropyl, C1-C6alkyl, S-alkyl, NR210 where R10 is hydrogen or C1-6alkyl, halogen, NO2, OH, CH2OC1-C6alkyl, CH2OH, or a 5- or 6-membered aryl; with the proviso that the compounds [4-(1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]-2-propionic acid, sodium salt and [4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetic acid are excluded; and pharmac

Abstract: A process and apparatus for the on-site delivery of a gas having improved purity to from a container filled with liquid under pressure and integrated with a purifier. In the process a portion of the liquid is converted to vapor by reducing the pressure in the container and expanding the thus formed vapor through a pressure reducer generating refrigeration. The cooled vapor is warmed against incoming vapor prior to exit from the purifier.